IDEAYA Biosciences, Inc. Common Stock (IDYA) is a publicly traded Healthcare sector company. As of September 1, 2026, IDYA trades at $40.10 with a market cap of $3.87B and a P/E ratio of -20.72. IDYA moved +0.00% today. Year to date, IDYA is +16.00%; over the trailing twelve months it is +63.34%. Its 52-week range spans $13.45 to $42.68. Analyst consensus is strong buy with an average price target of $51.55. Rallies surfaces IDYA's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies AI research for IDYA combines live market data, fundamentals, news, analyst context, hedge fund holdings, politician trades, insider activity, and risk factors into a ticker-specific research workflow.
| Metric | Value |
|---|---|
| Price | $40.10 |
| Market Cap | $3.87B |
| P/E Ratio | -20.72 |
| EPS | $-1.92 |
| Dividend Yield | 0.00% |
| 52-Week High | $42.68 |
| 52-Week Low | $13.45 |
| Volume | 1.22K |
| Avg Volume | 0 |
| Revenue (TTM) | $234.13M |
| Net Income | $-175.02M |
| Gross Margin | 0.00% |
11 analysts cover IDYA: 0 strong buy, 10 buy, 1 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $51.55.